Tomi Numminen

Tomi Numminen is an experienced executive with a diverse leadership background in the biotechnology and business sectors. Currently serving as the Executive Chairman and CEO at Bioretec Ltd. since May 2016, Tomi also holds the position of Chairman of the Board of Directors at Uniogen. As a founder and Chairman of the Board of Directors at Endicum Ltd. since January 2010, Tomi has demonstrated long-term commitment to organizational leadership. Additional roles include past Chairmanships at Injeq and Labrox, and directorships at BBS-Bioactive Bone Substitutes Oy, Aucor Oy, and Ocuspecto Oy. Tomi previously served as CEO and COO of ReBio Technologies Limited and has experience as a Business Unit Director at Purac Biomaterials. Tomi holds a Master of Science degree in Economics from the University of Turku, obtained between 1992 and 1997.